Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incense-burning smoke ingredient Auramine enhances lincRNA-p21 expression for chemosensitization in p53-mutated non-small cell lung cancer.

Journal of hazardous materials - 15 Sept 2024

Huang Hsuan-Yu, Chen Chia-Hung, Cheng Fang-Ju, Wang Bo-Wei, Tu Chih-Yen, Chen Yun-Ju, He Yu-Hao, Yao Chun-Hsu, Huang Wei-Chien

Abstract excerpt

Incense-burning smoke is a deleterious air pollutant that initiates cytotoxic effects by inducing apoptosis in lung epithelial cells and also acts as a risk factor for lung cancers. Auramine, an ingredient of incense smoke, has been implicated in tumor progression and cellular sensitivity in non-small cell lung cancer (NSCLC) towards anti-cancer agents through unclear mechanisms. Tumor protein p53...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Apoptosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Drug Resistance, Neoplasm

Share to Lung Neoplasms

Share to RNA, Long Noncoding

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 39047551
DOI: 10.1016/j.jhazmat.2024.135105

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incense-burning smoke ingredient Auramine enhances lincRNA-p21 expression for chemosensitization in p53-mutated non-small cell lung cancer.PMID 39047551Read ↗

Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancerSemantic proximity Read ↗

Circular RNA circNIPBL regulates TP53-H179R mutations in NNK-induced bronchial epithelial carcinogenesis.Semantic proximity Read ↗

Nicotine Promotes WRL68 Cells Proliferation Due to the Mutant p53 Gain-of-Function by Activating CDK6-p53-RS-PIN1-STAT1 Signaling Pathway.Semantic proximity Read ↗

(−)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancerSemantic proximity Read ↗

LincRNA-p21 knockdown enhances radiosensitivity of hypoxic tumor cells by reducing autophagy through HIF-1/Akt/mTOR/P70S6K pathwaySemantic proximity Read ↗

Lutein inhibits tumor progression through the ATR /Chk1/p53 signaling pathway in non‐small cell lung cancerSemantic proximity Read ↗

p53 and lung cancer.Semantic proximity Read ↗

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.Semantic proximity Read ↗

Effect of microRNA-21 on multidrug resistance reversal in A549/DDP human lung cancer cellsSemantic proximity Read ↗

DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-AdenosineSemantic proximity Read ↗

High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancerSemantic proximity Read ↗

Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.